Cargando…
Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19()
Pneumonia caused by coronavirus, which originated in Wuhan, China, in late 2019, has been spread around the world already becoming a pandemic. Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19. Many of these patients deteriorate rapidly and require...
Autores principales: | Hernández, A., Papadakos, P.J., Torres, A., González, D.A., Vives, M., Ferrando, C., Baeza, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203037/ http://dx.doi.org/10.1016/j.redare.2020.05.002 |
Ejemplares similares
-
Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19
por: Hernández, A., et al.
Publicado: (2020) -
Adjuvant therapies in critical care: steroids in community-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2017) -
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
por: Stocchi, Fabrizio, et al.
Publicado: (2016) -
Vitamin D deficiency and supplementation in critical illness—the known knowns and known unknowns
por: Nair, Priya, et al.
Publicado: (2018) -
Could Physical Therapy Interventions Be Adopted in the Management of Critically Ill Patients with COVID-19? A Scoping Review
por: Bernal-Utrera, Carlos, et al.
Publicado: (2021)